[Myelodysplastic syndrome with rapid disease progression after withdrawal of treatment with azacitidine].

Ueda, Hideya; Yoshida, Masahiro; Kanashima, Hiroshi; Nakao, Takafumi; Sugiyama, Hiroyuki; Yamane, Takahisa

Ueda, Hideya; Yoshida, Masahiro; Kanashima, Hiroshi; Nakao, Takafumi; Sugiyama, Hiroyuki; Yamane, Takahisa.

Affiliation

Ueda H; Dept. of Hematology, Osaka City General Hospital.

Gan To Kagaku Ryoho ; 41(7): 875-7, 2014 Jul.

Article in Ja | MEDLINE | ID: mdl-25131875

Subject(s)

Antimetabolites, Antineoplastic/therapeutic use; Azacitidine/therapeutic use; Myelodysplastic Syndromes/diagnosis; Aged; Disease Progression; Fatal Outcome; Female; Humans; Leukemia, Myeloid, Acute/diagnosis; Myelodysplastic Syndromes/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Antimetabolites, Antineoplastic Type of study: Diagnostic_studies Limits: Aged / Female / Humans Language: Ja Journal: Gan To Kagaku Ryoho Year: 2014 Document type: Article Country of publication: Japan

Search on Google

Add to My VHL

XML

PubMed Links